Dr. Trevor Martin is the co-founder and CEO of Mammoth Biosciences, a biotechnology company based in the San Francisco Bay Area that is harnessing the diversity of nature to power the next generation of curative CRISPR therapies for genetic diseases, as well as improving human health and wellbeing. Through its AI enabled discovery, and development of novel CRISPR systems, including from co-founder and Nobel Prize winner Jennifer Doudna’s lab, Mammoth is enabling the full potential of its platform to read and write the code of life. Trevor earned his BA from Princeton University and his Ph.D. from Stanford. His scientific work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is an EY Entrepreneur of the Year 2021. Mammoth has raised over $465M from leading investors in the US and internationally.